share_log

HC Wainwright & Co. Maintains Buy on ImmunoPrecise Antibodies, Lowers Price Target to $7

HC Wainwright & Co. Maintains Buy on ImmunoPrecise Antibodies, Lowers Price Target to $7

HC Wainwright & Co. 维持对ImmunoPrecise Antibodies的买入评级,将目标价下调至7美元。
Benzinga ·  12/12 01:58  · 评级/大行评级

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ImmunoPrecise Antibodies (NASDAQ:IPA) with a Buy and lowers the price target from $9 to $7.

HC Wainwright & Co. 分析师Swayampakula Ramakanth维持对免疫精准抗体(纳斯达克:IPA)的买入评级,并将目标价格从9美元下调至7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发